↓ Skip to main content

Integrin alpha-V is an important driver in pancreatic adenocarcinoma progression

Overview of attention for article published in Journal of Experimental & Clinical Cancer Research, June 2021
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • Above-average Attention Score compared to outputs of the same age and source (63rd percentile)

Mentioned by

twitter
2 X users

Citations

dimensions_citation
15 Dimensions

Readers on

mendeley
24 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Integrin alpha-V is an important driver in pancreatic adenocarcinoma progression
Published in
Journal of Experimental & Clinical Cancer Research, June 2021
DOI 10.1186/s13046-021-01946-2
Pubmed ID
Authors

Marius Kemper, Alina Schiecke, Hanna Maar, Sergey Nikulin, Andrey Poloznikov, Vladimir Galatenko, Michael Tachezy, Florian Gebauer, Tobias Lange, Kristoffer Riecken, Alexander Tonevitsky, Achim Aigner, Jakob Izbicki, Udo Schumacher, Daniel Wicklein

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 24 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 24 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 6 25%
Student > Ph. D. Student 6 25%
Other 1 4%
Lecturer 1 4%
Unspecified 1 4%
Other 4 17%
Unknown 5 21%
Readers by discipline Count As %
Agricultural and Biological Sciences 4 17%
Pharmacology, Toxicology and Pharmaceutical Science 3 13%
Medicine and Dentistry 3 13%
Biochemistry, Genetics and Molecular Biology 3 13%
Unspecified 1 4%
Other 2 8%
Unknown 8 33%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 28 June 2021.
All research outputs
#15,181,325
of 25,392,582 outputs
Outputs from Journal of Experimental & Clinical Cancer Research
#874
of 2,383 outputs
Outputs of similar age
#218,385
of 454,083 outputs
Outputs of similar age from Journal of Experimental & Clinical Cancer Research
#24
of 68 outputs
Altmetric has tracked 25,392,582 research outputs across all sources so far. This one is in the 38th percentile – i.e., 38% of other outputs scored the same or lower than it.
So far Altmetric has tracked 2,383 research outputs from this source. They receive a mean Attention Score of 4.8. This one has gotten more attention than average, scoring higher than 61% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 454,083 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 49th percentile – i.e., 49% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 68 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 63% of its contemporaries.